Xiaoping Hong1,2, Shuhui Meng2, Donge Tang2, Tingting Wang2, Liping Ding2, Haiyan Yu2, Heng Li2, Dongzhou Liu2, Yong Dai2, Min Yang1. 1. Department of Rheumatology and Immunology, Southern Medical University, Nanfang Hospital, Guangzhou, China. 2. Department of Rheumatology and Immunology, Department of Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen People's Hospital (The Second Clinical Medical College of Jinan University, The First Affiliated Hospital Southern University of Science and Technology), Shenzhen, China.
Abstract
Objective: Primary Sjögren's syndrome (pSS) is a systemic autoimmune disease, and its pathogenetic mechanism is far from being understood. In this study, we aimed to explore the cellular and molecular mechanisms that lead to pathogenesis of this disease. Methods: We applied single-cell RNA sequencing (scRNA-seq) to 57,288 peripheral blood mononuclear cells (PBMCs) from five patients with pSS and five healthy controls. The immune cell subsets and susceptibility genes involved in the pathogenesis of pSS were analyzed. Flow cytometry was preformed to verify the result of scRNA-seq. Results: We identified two subpopulations significantly expand in pSS patients. The one highly expressing cytotoxicity genes is named as CD4+ CTLs cytotoxic T lymphocyte, and another highly expressing T cell receptor (TCR) variable gene is named as CD4+ TRAV13-2+ T cell. Flow cytometry results showed the percentages of CD4+ CTLs, which were profiled with CD4+ and GZMB+ staining; the total T cells of 10 patients with pSS were significantly higher than those of 10 healthy controls (P= 0.008). The expression level of IL-1β in macrophages, TCL1A in B cells, as well as interferon (IFN) response genes in most cell subsets was upregulated in the patients with pSS. Susceptibility genes including HLA-DRB5, CTLA4, and AQP3 were highly expressed in patients with pSS. Conclusions: Our data revealed disease-specific immune cell subsets and provided some potential new targets of pSS. Specific expansion of CD4+ CTLs may be involved in the pathogenesis of pSS, which might give valuable insights for therapeutic interventions of pSS.
Objective: Primary Sjögren's syndrome (pSS) is a systemic autoimmune disease, and its pathogenetic mechanism is far from being understood. In this study, we aimed to explore the cellular and molecular mechanisms that lead to pathogenesis of this disease. Methods: We applied single-cell RNA sequencing (scRNA-seq) to 57,288 peripheral blood mononuclear cells (PBMCs) from five patients with pSS and five healthy controls. The immune cell subsets and susceptibility genes involved in the pathogenesis of pSS were analyzed. Flow cytometry was preformed to verify the result of scRNA-seq. Results: We identified two subpopulations significantly expand in pSSpatients. The one highly expressing cytotoxicity genes is named as CD4+ CTLs cytotoxic T lymphocyte, and another highly expressing T cell receptor (TCR) variable gene is named as CD4+ TRAV13-2+ T cell. Flow cytometry results showed the percentages of CD4+ CTLs, which were profiled with CD4+ and GZMB+ staining; the total T cells of 10 patients with pSS were significantly higher than those of 10 healthy controls (P= 0.008). The expression level of IL-1β in macrophages, TCL1A in B cells, as well as interferon (IFN) response genes in most cell subsets was upregulated in the patients with pSS. Susceptibility genes including HLA-DRB5, CTLA4, and AQP3 were highly expressed in patients with pSS. Conclusions: Our data revealed disease-specific immune cell subsets and provided some potential new targets of pSS. Specific expansion of CD4+ CTLs may be involved in the pathogenesis of pSS, which might give valuable insights for therapeutic interventions of pSS.
Authors: Bieke Broux; Kim Pannemans; Xin Zhang; Silva Markovic-Plese; Tom Broekmans; Bert O Eijnde; Bart Van Wijmeersch; Veerle Somers; Piet Geusens; Susanne van der Pol; Jack van Horssen; Piet Stinissen; Niels Hellings Journal: J Autoimmun Date: 2011-11-26 Impact factor: 7.094
Authors: Arne Hansen; Marcus Odendahl; Karin Reiter; Annett M Jacobi; Eugen Feist; Jürgen Scholze; Gerd R Burmester; Peter E Lipsky; Thomas Dörner Journal: Arthritis Rheum Date: 2002-08
Authors: Tommaso Andreani; Linda M Slot; Samuel Gabillard; Carsten Strübing; Claus Reimertz; Veeranagouda Yaligara; Aleida M Bakker; Reza Olfati-Saber; René E M Toes; Hans U Scherer; Franck Augé; Deimantė Šimaitė Journal: NAR Genom Bioinform Date: 2022-07-13
Authors: Samuel Alber; Sugandh Kumar; Jared Liu; Zhi-Ming Huang; Diana Paez; Julie Hong; Hsin-Wen Chang; Tina Bhutani; Lianne S Gensler; Wilson Liao Journal: Front Immunol Date: 2022-05-13 Impact factor: 8.786
Authors: Cecilia S Lindestam Arlehamn; Alessandro Sette; Rekha Dhanwani; João Rodrigues Lima-Junior; Ashu Sethi; John Pham; Gregory Williams; April Frazier; Yaqian Xu; Amy W Amara; David G Standaert; Jennifer G Goldman; Irene Litvan; Roy N Alcalay; Bjoern Peters; David Sulzer Journal: NPJ Parkinsons Dis Date: 2022-03-21